Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | MK-6598 |
| Trade Name | |
| Synonyms | MK 6598|MK6598 |
| Drug Descriptions |
MK-6598 inhibits IL4I1, potentially resulting in antitumor activity (Cancer Res (2025) 85 (8_Supplement_2): CT074). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| MK-6598 | MK-6598 | 0 | 1 |
| MK-6598 + Pembrolizumab | MK-6598 Pembrolizumab | 0 | 1 |